iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.25 +0.07 (5.93%)
Previous Close $1.18    52 Week High $0.80 
Open $1.25    52 Week Low $0.34 
Day High $1.31    P/E N/A 
Day Low $1.21    EPS $-0.08 
Volume 2,082,641       

IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.25 +0.07 (5.93%)
Previous Close $1.18    52 Week High $0.80 
Open $1.25    52 Week Low $0.34 
Day High $1.31    P/E N/A 
Day Low $1.21    EPS $-0.08 
Volume 2,082,641